Search results
Results From The WOW.Com Content Network
Alcon Inc. Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
Product recall. A product recall is a request from a manufacturer to return a product after the discovery of safety issues or product defects that might endanger the consumer or put the maker/seller at risk of legal action. The recall is an effort to limit ruination of the corporate image and limit liability for corporate negligence, which can ...
Recalls are generally covered by the manufacturer (though if the vehicle is more than 10 years old on the date the problem is identified, it’s not required to be covered).
Types. The FDA classifies soft contact lenses into four groups for the US market. They are also subcategorized into 1st generation, 2nd generation, and 3rd generation lens materials. [6] These 'water-loving' soft contact lens materials are categorized as "Conventional Hydrophilic Material Groups ("-filcon"): Group. Water Content.
To date, the CPSC added, there have been 103 incidents of these glasses breaking at the base — resulting in 56 injuries. 580,000 glass coffee mugs recalled because they can break when filled ...
An airbag manufacturer since 1988 with a command of roughly 20 percent of the market, the Takata Corporation lost it all after the most expensive product recall in history.
old Logo. The United States Consumer Product Safety Commission (USCPSC, CPSC, or commission) is an independent agency of the United States government.The CPSC seeks to promote the safety of consumer products by addressing "unreasonable risks" of injury (through coordinating recalls, evaluating products that are the subject of consumer complaints or industry reports, etc.); developing uniform ...
Novartis (NVS) has worked aggressively to purchase Alcon (ACL), a major eye-care company, from Nestlé. The deal-making started a couple of years ago when Novartis shelled out $10.4 billion to ...